Prime-boost immunization with HA/C3d DNA followed by a recombinant pseudorabies virus boost enhanced protective immunity against H3N2 swine influenza virus in mice

Research in Veterinary Science

Volumn 88, Issue 2, 2010, Pages 345-351

  Li, Guo Xin ^a,b   Zhou, Yan Jun ^a   Yu, Hai ^a   Tian, Zhi Jun ^b   Yan, Li Ping ^a   Zhang, Qiang ^c   Hu, Shou Ping ^b   Tong, Guang Zhi ^a,b  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b Harbin Veterinary Research Institute   (China)

^c Plants and Foods Inspection and Quarantine Shanghai Entry Exit Inspection   (China)

Author keywords

C3d; DNA vaccines; Prime boost; Pseudorabies virus; Swine influenza virus

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA IMMUNIZATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; INFLUENZA; INFLUENZA VIRUS A H3N2; INTERSTITIAL PNEUMONIA; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PSEUDORABIES HERPETOVIRUS; SWINE INFLUENZA VIRUS; TISSUE DISTRIBUTION; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS PATHOGENESIS; VIRUS RECOMBINANT;

ANIMALS; COMPLEMENT C3D; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTININS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INTERFERON-GAMMA; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; PSEUDORABIES VACCINES; RECOMBINANT PROTEINS; VACCINES, DNA;

MURINAE; MUS; SIMIAN IMMUNODEFICIENCY VIRUS; SUID HERPESVIRUS 1; SWINE INFLUENZA VIRUS;

EID: 76849108227     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2009.09.005     Document Type: Article

References (34)

1. Amara R.R., Villinger F., Altman J.D., Lydy S.L., O'Neil S.P., Staprans S.I., et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292 5514 (2001) 69-74
2. Bot A., Antohi S., and Bona C. Immune response of neonates elicited by somatic transgene vaccination with naked DNA. Front. Biosci. 2 (1997) d173-d188
3. Bounous D.I., Campagnoli R.P., and Brown J. Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes. Avian. Dis. 4 (1992) 1022-1027
4. Breathnach C.C., Clark H.J., Clark R.C., Olsen C.W., Townsend H.G., and Lunn D.P. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge. Vaccine 24 8 (2006) 1180-1190
5. Castrucci M.R., Donatelli I., Sidoli L., Barigazzi G., Kawaoka Y., and Webster R.G. Genetic reassortment between avian and human influenza A viruses in Italian pigs. Virology 193 1 (1993) 503-506
6. Chen Y., Xin X.G., Yang H.L., Li T., Li H.Y., Qiao C.L., et al. Establishment of an indirect ELISA for detection antibodies against swine influenza virus. Prog. Vet. Med. 4 (2007) 308-311 (in Chinese)
7. Choi Y.K., Goyal S.M., and Joo H.S. Retrospective analysis of etiologic agents associated with respiratory diseases in pigs. Can. Vet. J. 44 9 (2003) 735-737
8. Dea S., Bilodeau R., Sauvageau R., and Martineau G.P. Outbreaks in Quebec pig farms of respiratory and reproductive problems associated with encephalomyocarditis virus. J. Vet. Diagn. Invest. 3 4 (1991) 275-282
9. Dégano P., Schneider J., Hannan C.M., Gilbert S.C., and Hill A.V. Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models. Vaccine 18 7-8 (1999) 623-632
10. Dory D., Fischer T., Béven V., Cariolet R., Rziha H.J., and Jestin A. Prime-boost immunization using DNA vaccine and recombinant Orf virus protects pigs against Pseudorabies virus (Herpes suid 1). Vaccine 24 37-39 (2006) 6256-6263
11. Endo A., Itamura S., Iinuma H., Funahashi S., Shida H., Koide F., et al. Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus. J. Gen. Virol. 72 Pt. 3 (1991) 699-703
12. González-Fernández A., and Milstein C. Low antigen dose favours selection of somatic mutants with hallmarks of antibody affinity maturation. Immunology 93 2 (1998) 149-153
13. Graham B.S., Koup R.A., Roederer M., Bailer R.T., Enama M.E., Moodie Z., et al. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. J. Infect. Dis. 194 12 (2006) 1650-1660
14. Ito T., Couceiro J.N., Kelm S., Baum L.G., Krauss S., Castrucci M.R., et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol. 72 9 (1998) 7367-7373
15. Karasin A.I., Schutten M.M., Cooper L.A., Smith C.B., Subbarao K., Anderson G.A., et al. Genetic characterization of H3N2 influenza viruses isolated from pigs in North America, 1977-1999: evidence for wholly human and reassortant virus genotypes. Virus Res. 68 1 (2000) 71-85
16. Larsen D.L., Karasin A., and Olsen C.W. Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting. Vaccine 19 20-22 (2001) 2842-2853
17. Li G.X., Tian Z.J., Yu H., Jin Y.Y., Hou S.H., Zhou Y.J., et al. Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus. Res. Vet. Sci. Vet. Sci. 86 3 (2009) 406-413
18. Macklin M.D., McCabe D., McGregor M.W., Neumann V., Meyer T., et al. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. J. Virol. 2 (1998) 1491-1496
19. Meseda C.A., Elkins K.L., Merchlinsky M.J., and Weir J.P. Prime-boost immunization with DNA and modified vaccinia virus Ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone. J. Infect. Dis. 186 8 (2002) 1065-1073
20. Newman M.J. Heterologous prime-boost vaccination strategies for HIV-1: augmenting cellular immune responses. Curr. Opin. Investig. Drugs 3 3 (2002) 374-378
21. Olsen C.W. The emergence of novel swine influenza viruses in North America. Virus Res. 2 (2002) 199-210
22. Ramshaw I.A., and Ramsay A.J. The prime-boost strategy: exciting prospects for improved vaccination. Immunol. Today 21 4 (2000) 163-165
23. Richard J., and Anderson J.S. Plasmid DNA and viral vector-based vaccines for the treatment of cancer. Vaccine 25S (2007) B24-B34
24. Robinson H.L., Boyle C.A., Feltquate D.M., Morin M.J., Santoro J.C., and Webster R.G. DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein expressing DNAs. J. Infect. Dis. 176 (1997) S50-S55
25. Ross T.M., Xu Y., Bright R.A., and Robinson H.L. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat. Immunol. 1 2 (2000) 127-131
26. Schneider J., Gilbert S.C., Blanchard T.J., Hanke T., Robson K.J., Hannan C.M., et al. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4 4 (1998) 397-402
27. Sharpe S., Polyanskaya N., Dennis M., Sutter G., Hanke T., Erfle V., et al. Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity. J. Gen. Virol. 82 Pt. 9 (2001) 2215-2223
28. Tang M., Harp J.A., and Wesley R.D. Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2). Arch. Virol. 11 (2002) 2125-2141
29. Tian Z.J., Zhou G.H., Zheng B.L., Qiu H.J., Ni J.Q., Yang H.L., et al. A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge. Vet. Immunol. Immunopathol. 111 (2006) 211-218
30. Torres C.A., Yang T.K., Mustafa F., and Robinson H.L. DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses. Vaccine 9-10 (2000) 805-814
31. Wang S., Parker C., Taaffe J., Solórzano A., García-Sastre A., and Lu S. Heterologous HA DNA vaccine prime-inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses. Vaccine 26 29-30 (2008) 3626-3633
32. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., and Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56 1 (1992) 152-179
33. Wesley R.D., Tang M., and Lager K.M. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine 25-26 (2004) 3427-3434
34. Yoon I.J., Joo H.S., Christianson W.T., Kim H.S., Collins J.E., Morrison R.B., et al. An indirect fluorescent antibody test for the detection of antibody to swine infertility and respiratory syndrome virus in swine sera. J. Vet. Diagn. Invest. 4 (1992) 144-147